- Markets
- Healthcare
- KMSMEDI
KMSMEDI
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
KMS Medisurgi Approved Change In Designation Of Siddharth Gaurang Kanakia To MD
May 3 (Reuters) - KMS Medisurgi Ltd KMSM.BO:
REKHA DEVANG KANAKIA RESIGNS AS MD
APPROVED CHANGE IN DESIGNATION OF SIDDHARTH GAURANG KANAKIA TO MD
Source text for Eikon: ID:nBSE3QLD4h
Further company coverage: KMSM.BO
(([email protected];))
May 3 (Reuters) - KMS Medisurgi Ltd KMSM.BO:
REKHA DEVANG KANAKIA RESIGNS AS MD
APPROVED CHANGE IN DESIGNATION OF SIDDHARTH GAURANG KANAKIA TO MD
Source text for Eikon: ID:nBSE3QLD4h
Further company coverage: KMSM.BO
(([email protected];))
Events:
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does KMS Medisurgi do?
KMS Medisurgi is a company in India engaged in ethical marketing and distribution of various surgical and medical equipment. They also undertake job work of coating various substrates with adhesive.
Who are the competitors of KMS Medisurgi?
KMS Medisurgi major competitors are Amkay Products, GKB Ophthalmics, Centenial Surgical, Shree Pacetronix, Transpact Enterprise, Laser Eyecare, Raaj Medisafe India. Market Cap of KMS Medisurgi is ₹41 Crs. While the median market cap of its peers are ₹36 Crs.
Is KMS Medisurgi financially stable compared to its competitors?
KMS Medisurgi seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does KMS Medisurgi pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. KMS Medisurgi latest dividend payout ratio is 3.64% and 3yr average dividend payout ratio is 4.73%
How has KMS Medisurgi allocated its funds?
Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances
How strong is KMS Medisurgi balance sheet?
Balance sheet of KMS Medisurgi is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of KMS Medisurgi improving?
The profit is oscillating. The profit of KMS Medisurgi is ₹0.45 Crs for Mar 2024, ₹0.57 Crs for Mar 2023 and ₹0.22 Crs for Mar 2022
Is the debt of KMS Medisurgi increasing or decreasing?
Yes, The debt of KMS Medisurgi is increasing. Latest debt of KMS Medisurgi is ₹0.52 Crs as of Sep-24. This is greater than Mar-24 when it was -₹0.29 Crs.
Is KMS Medisurgi stock expensive?
KMS Medisurgi is not expensive. Latest PE of KMS Medisurgi is 72.0, while 3 year average PE is 79.27. Also latest EV/EBITDA of KMS Medisurgi is 0 while 3yr average is 24.46.
Has the share price of KMS Medisurgi grown faster than its competition?
KMS Medisurgi has given better returns compared to its competitors. KMS Medisurgi has grown at ~32.86% over the last 5yrs while peers have grown at a median rate of 19.0%
Is the promoter bullish about KMS Medisurgi?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in KMS Medisurgi is 74.42% and last quarter promoter holding is 74.42%.
Are mutual funds buying/selling KMS Medisurgi?
There is Insufficient data to gauge this.